dipyrone has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Advani, SH; Chitnis, MP; Kamath, NS; Parekh, HK | 1 |
1 other study(ies) available for dipyrone and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Dipyrone enhances intracellular accumulation and cytotoxicity of adriamycin in human chronic myeloid leukemia cells.
Topics: Cell Survival; Dipyrone; DNA; Doxorubicin; Drug Evaluation, Preclinical; Drug Synergism; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Thymidine; Tumor Cells, Cultured | 1991 |